According to Cytosorbents's latest financial reports the company's current EPS (TTM) is -$0.84. In 2022 the company made an earnings per share (EPS) of -$1.05 a decrease over its 2021 EPS that were of -$0.80.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$0.81 | -22.92% |
2022 | -$1.05 | 31.58% |
2021 | -$0.80 | 171.43% |
2020 | -$0.29 | -64.41% |
2019 | -$0.83 | 5.36% |
2018 | -$0.79 | 86.67% |
2017 | -$0.42 | -36.17% |
2016 | -$0.66 | 27.03% |
2015 | -$0.52 | -67.55% |
2014 | -$1.60 | 14.02% |
2013 | -$1.40 | 33.33% |
2012 | -$1.05 | -25% |
2011 | -$1.40 | -20% |
2010 | -$1.76 | -37.5% |
2009 | -$2.81 | -50% |
2008 | -$5.62 | -11.11% |
2007 | -$6.32 | -80.88% |
2006 | -$33.05 |